In vitro antibacterial and morphological effects of the urushiol component of the sap of the Korean lacquer tree (Rhus vernicifera stokes) on Helicobacter pylori

Journal of Korean Medical Science

Volumn 25, Issue 3, 2010, Pages 399-404

  Suk, Ki Tae ^a   Kim, Hyun Soo ^b   Kim, Moon Young ^b   Kim, Jae Woo ^b   Uh, Young ^b   Jang, In Ho ^b   Kim, Soo Ki ^b   Choi, Eung Ho ^b   Kim, Myong Jo ^c   Joo, Jung Soo ^d   Baik, Soon Koo ^b  

^a Hallym University College of Medicine   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c Kangwon National University   (South Korea)

^d Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Anti infective agents; Helicobacter pylori; Urushiol

Indexed keywords

ANTIINFECTIVE AGENT; CATECHOL DERIVATIVE; URUSHIOL;

ARTICLE; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; POISON IVY; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; CATECHOLS; CELL MEMBRANE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR STRUCTURE; RHUS;

EID: 77952312075     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.3.399     Document Type: Article

References (23)

1. Ferreira AC, Isomoto H, Moriyama M, Fujioka T, Machado JC, Yamaoka Y. Helicobacter and gastric malignancies. Helicobacter 2008; 13 (Suppl 1): 28-34.
2. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis 2008; 40: 619-26.
3. Marzio L, Cellini L, Angelucci D. Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. Dig Liver Dis 2003; 35: 20-3.
4. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
5. Elsohly MA, Adawadkar PD, Benigni DA, Watson ES, Little TL Jr. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes. J Med Chem 1986; 29: 606-11.
6. Kim M, Choi Y, Kim W, Kwak S. Antioxidative activity of urushiol derivatives from the sap of lacquer tree. Korean J Plant Resources 1997; 10: 227-30.
7. Kim M, Kim C, Kwak S. Antifungal activity of urushiol component in the sap of Korean lacquer tree (Rhus vernicifera Stokes). Korean J Plant Resources 1997; 10: 231-4.
8. Horii T, Mase K, Suzuki Y, Kimura T, Ohta M, Maekawa M, Kanno T, Kobayashi M. Antibacterial activities of beta-lactamase inhibitors associated with morphological changes of cell wall in Helicobacter pylori. Helicobacter 2002; 7: 39-45.
9. Adeniyi BA, Anyiam FM. In vitro anti-Helicobacter pylori potential of methanol extract of Allium ascalonicum Linn. (Liliaceae) leaf: susceptibility and effect on urease activity. Phytother Res 2004; 18: 358-61.
10. Tecder-Unal M, Can F, Demirbilek M, Karabay G, Tufan H, Arslan H. The bactericidal and morphological effects of peroxynitrite on Helicobacter pylori. Helicobacter 2008; 13: 42-8.
11. Stamatis G, Kyriazopoulos P, Golegou S, Basayiannis A, Skaltsas S, Skaltsa H. In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J Ethnopharmacol 2003; 88: 175-9.
12. Kamiji MM, de Oliveira RB. Non-antibiotic therapies for Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2005; 17: 973-81.
13. Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimicrob Agents 2001; 18: 85-8.
14. Nostro A, Cellini L, Di Bartolomeo S, Di Campli E, Grande R, Cannatelli MA, Marzio L, Alonzo V. Antibacterial effect of plant extracts against Helicobacter pylori. Phytother Res 2005; 19: 198-202.
15. Lascols C, Bryskier A, Soussy CJ, Tankovic J. Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin. J Antimicrob Chemother 2001; 48: 738-40.
16. Hassan IJ, Stark RM, Greenman J, Millar MR. Activities of beta-lactams and macrolides against Helicobacter pylori. Antimicrob Agents Chemother 1999; 43: 1387-92.
17. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110: 926-38.
18. Park MJ, Kim JS, Yim JY, Jung HC, Song IS, Yu ES, Lee JJ, Huh CS, Baek YJ. The suppressive effect of a fermented milk containing lactobacilli on Helicobacter pylori in human gastric mucosa. Korean J Gastroenterol 2001; 38: 233-40.
19. Wang YC, Huang TL. Anti-Helicobacter pylori activity of Plumbago zeylanica L. FEMS Immunol Med Microbiol 2005; 43: 407-12.
20. Millar MR, Pike J. Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrob Agents Chemother 1992; 36: 185-7.
21. Blacky A, Makristathis A, Apfalter P, Willinger B, Rotter ML, Hirschl AM. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole. Eur J Clin Microbiol Infect Dis 2005; 24: 276-9.
22. Xia Z, Miyakoshi T, Yoshida T. Lipoxygenase-catalyzed polymerization of phenolic lipids suggests a new mechanism for allergic contact dermatitis induced by urushiol and its analogs. Biochem Biophys Res Commun 2004; 315: 704-9.
23. Harigaya S, Honda T, Rong L, Miyakoshi T, Chen CL. Enzymatic dehydrogenative polymerization of urushiols in fresh exudates from the lacquer tree, Rhus vernicifera DC. J Agric Food Chem 2007; 55: 2201-8.